In Table 5 on page 2056 in the 3 September 2009 issue, the data for cases of typhlitis in patients not treated with dexrazoxane and in those treated with dexrazoxane are transposed. The corrected Table 5 is shown below.

Table 5

Grade 3 and 4 toxicity with or without dexrazoxane

Without dexrazoxaneWith dexrazoxane
Count (n = 108)Incidence, %Count (n = 106)Incidence, %
ANC grade 4* 84 77.8 99 93.4 
ANC grade 3 8.3 0.9 
Platelets* 32 29.6 77 72.6 
Hemoglobin* 44 40.7 64 60.4 
Thrombosis* 0.9 3.8 
Infection, not otherwise specified/unknown* 48 44.4 75 70.8 
Sepsis* 8.4 18 17.0 
Typhlitis 2.8 8.5 
Pulmonary* 2.8 13 12.3 
Cardiac function 1.9 
Peripheral nervous system/central nervous system 3/0 2.8/0 2/1 1.9/0.9 
Stomatitis 31 28.7 30 28.3 
Vomiting/nausea 10 9.3 10 9.4 
Allergic reaction 1.9 6.6 
Secondary malignancy 0.9 2.8 
Without dexrazoxaneWith dexrazoxane
Count (n = 108)Incidence, %Count (n = 106)Incidence, %
ANC grade 4* 84 77.8 99 93.4 
ANC grade 3 8.3 0.9 
Platelets* 32 29.6 77 72.6 
Hemoglobin* 44 40.7 64 60.4 
Thrombosis* 0.9 3.8 
Infection, not otherwise specified/unknown* 48 44.4 75 70.8 
Sepsis* 8.4 18 17.0 
Typhlitis 2.8 8.5 
Pulmonary* 2.8 13 12.3 
Cardiac function 1.9 
Peripheral nervous system/central nervous system 3/0 2.8/0 2/1 1.9/0.9 
Stomatitis 31 28.7 30 28.3 
Vomiting/nausea 10 9.3 10 9.4 
Allergic reaction 1.9 6.6 
Secondary malignancy 0.9 2.8 

Significant grade 3 toxicities that occurred in more than 5% of patients, all grade 4 toxicities, and specific targeted toxicities (pulmonary, cardiac, peripheral nervous system) are included above. Except as specified (eg, ANC), the numbers represent combined grade 3 and grade 4 toxicities.

ANC indicates absolute neutrophil count.

*

Statistically significantly different (log-rank test, P ≤ .05).

Includes diffusion capacity for carbon monoxide, vital capacity, pulmonary/functional, and oxygen saturation.

Central nervous system includes mood, cortical, and cerebellar.

Sign in via your Institution